Xrcc2 modulates spontaneous and radiation-induced tumorigenesis in Apc min/+ mice

Molecular Cancer Research

Volumn 8, Issue 9, 2010, Pages 1227-1233

  Haines, Jackie W ^a   Coster, Margaret R ^a   Adam, Julie ^b   Cheeseman, Michael ^c   Ainsbury, Elizabeth A ^a   Thacker, John ^b,d   Bouffler, Simon D ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c Medical Research Council Harwell Institute   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; XRCC2 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BREAST TUMOR; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOSITY LOSS; INTESTINE POLYP; INTESTINE TUMOR; LIFESPAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; X IRRADIATION;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; DNA-BINDING PROTEINS; FEMALE; INTESTINAL NEOPLASMS; LOSS OF HETEROZYGOSITY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PRECANCEROUS CONDITIONS; X-RAYS;

MUS;

EID: 77957114317     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0089     Document Type: Article

References (32)

1. Mullenders L, Atkinson M, Paretzke H, Sabatier L, Bouffler S. Assessing cancer risks of low-dose radiation. Nat Rev Cancer 2009;9:596-604.
2. Deans B, Griffin CS, Maconochie M, Thacker J. Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice. EMBO J 2000;19:6675-85.
3. O'Regan P, Wilson C, Townsend S, Thacker J. XRCC2 is a nuclear RAD51-like protein required for damage-dependent RAD51 focus formation without the need for ATP binding. J Biol Chem 2001;276:22148-53. (Pubitemid 33647633)
4. Venkitaraman AR. Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J Cell Sci 2001;114:3591-8.
5. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 2002;21:8981-93.
6. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 in a population based series of breast cancer cases. Br J Cancer 2000;83:1301-8.
7. Antoniou AC, Pharoah PDP, McMullen G, Day NE, Ponder BAJ, Easton DF. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study. Genet Epidemiol 2001;21:1-18.
8. Braybrooke JP, Li J-L, Wu L, Caple F, Benson FE, Hickson ID. Functional interaction between the Bloom's syndrome helicase and the RAD51 paralog, RAD51L3 (RAD51D). J Biol Chem 2003;278:48357-66.
9. Goss KH, Risinger MA, Kordich JJ, et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 2002;297:2051-3.
10. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
11. Min, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci U S A 1993;90:8977-81.
12. Trasler J, Deng L, Melnyk S, et al. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis 2003;24:39-45.
13. Cho NL, Javid SH, Carothers AM, Redston M, Bertagnolli MM. Estrogen receptors α and β are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 2007;67:2366-72. (Pubitemid 46437055)
14. min/+ Mom1S mice. Proc Natl Acad Sci U S A 2005;102:2868-73.
15. Luongo C, Moser AR, Gledhill S, Dove WF. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 1994;54:5947-52.
16. Adam J, Deans B, Thacker J. A role for Xrcc2 in the early stages of mouse development. DNA Repair (Amst) 2007;6:224-34.
17. Haines J, Dunford R, Moody J, Ellender M, Cox R, Silver A. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development. Genes Chromosomes Cancer 2000;28:387-94.
18. Meindl A, Hellebrand H, Wiek C, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 2010;42:410-4.
19. Rafii S, O'Regan P, Xinarianos G, et al. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum Mol Genet 2002;11:1433-8.
20. Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11:1399-407.
21. Millikan RC, Player JS, Decotret AR, Tse CK, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:2326-34. (Pubitemid 41437832)
22. Cressman VL, Backlund DC, Hicks EM, Gowen LC, Godfrey V, Koller BH. Mammary tumor formation in p53- and BRCA1-deficient mice. Cell Growth Differ 1999;10:1-10.
23. Ludwig T, Fisher P, Ganesan S, Efstratiadis A. Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev 2001;15:1188-93.
24. McAllister KA, Bennett LM, Houle CD, et al. Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res 2002;62:990-4.
25. Liu X, Holstege H, van der Gulden H, et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci U S A 2007;104:12111-6.
26. Herschkowitz JI, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 2007;8:R76.
27. Orii KE, Lee Y, Kondo N, McKinnon PJ. Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development. Proc Natl Acad Sci U S A 2006;103:10017-22. (Pubitemid 43993615)
28. van der Houven van Oordt CW, Smits R, Williamson SL, et al. Intestinal and extra-intestinal tumor multiplicities in the Apc1638N mouse model after exposure to X-rays. Carcinogenesis 1997;18:2197-203.
29. Degg NL, Weil MM, Edwards A, et al. Adenoma multiplicity in irradiated Apc(Min) mice is modified by chromosome 16 segments from BALB/c. Cancer Res 2003;63:2361-3.
30. min/+ mice. PLoS One 2009;4:e4388.
31. Min/+ mice is enhanced by X irradiation with a characteristic age dependence. Radiat Res 2006;165:165-73.
32. Griffin CS, Simpson PJ, Wilson CR, Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol 2000;2:757-61.